航天電器(002025.SZ)擬申報實施電磁繼電器生產線條件建設項目
格隆匯6月30日丨航天電器(002025.SZ)公佈,公司擬申報實施電磁繼電器生產線條件建設項目,項目資金來源為申請國家專項撥款(不足部分公司自籌),該項目竣工驗收合格後形成的國有資產將計入轉增為國有資本公積或國有股權,由中國航天科工集團有限公司享有或持有。
公司擬投資建設的電磁繼電器生產線條件建設項目位於航天電器貴陽廠區,該項目建設內容包括新增設計軟件、注塑設備等工藝設備73台(套);預計項目總投資6700萬元;資金來源為申請國家專項撥款;建設週期24個月。項目建成後可滿足國家重點工程配套研製生產條件。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.